Considerable research efforts have been directed toward
the symptom
relief of Parkinson’s disease (PD) by attenuating dopamine
(DA) depletion. One common feature of these existing therapies is
their unavailability of preventing the neurodegenerative process of
dopaminergic neurons. (+)-Borneol, a natural highly lipid-soluble
bicyclic monoterpene, has been reported to regulate the levels of
monoamine neurotransmitters in the central nervous system and exhibit
neuroprotective effects. However, the effect of (+)-borneol on the
dopaminergic neuronal loss of methyl-4-phenyl-1,2,3,6-tetrahydropyridine
(MPTP)-induced PD mice is not defined. Herein, we first report that
30 mg/kg (+)-borneol significantly attenuated the motor deficits of
PD mice, which benefits from markedly increasing the level of DA and
decreasing the metabolic rate of DA in the striatum of conscious and
freely moving mouse detected by ultraperformance liquid chromatography
tandem mass spectrometry online combined with in vivo brain microdialysis
sampling. It is worth noting that the enhanced level of DA by (+)-borneol
was enabled by the reduction in loss of tyrosine hydroxylase-immunoreactive
dopaminergic neurons in the substantia nigra and striatum and promotion
of reserpine- or nomifensine-induced DA release in PD mice. Interestingly,
(+)-borneol evidently inhibited the decreased expression levels of
DA transporter (DAT) and vesicular monoamine transporter 2 (VMAT2)
on the MPTP mouse model of PD. Moreover, (+)-borneol suppressed the
neuroinflammation by inhibiting the production of IL-1β, IL-6,
and TNF-α and attenuated oxidative stress by decreasing the
level of MDA and increasing the activities of SOD and GSH-px in PD
mice. These findings demonstrate that (+)-borneol protects DA neurons
by inhibiting neuroinflammation and oxidative stress. Further research
work for the neuroprotection mechanism of (+)-borneol will focus on
reactive oxygen species-mediated apoptosis. Therefore, (+)-borneol
is a potential therapeutic candidate for retarding the neurodegenerative
process of PD.